[Federal Register Volume 60, Number 206 (Wednesday, October 25, 1995)]
[Notices]
[Page 54750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-26381]



-----------------------------------------------------------------------


SECURITIES AND EXCHANGE COMMISSION

Issuer Delisting; Notice of Application to Withdraw From Listing 
and Registration (U.S. Diagnostic Labs, Inc., Common Stock, $.001 Par 
Value); File No. 1-13392

October 19, 1995.
    U.S. Diagnostic Labs, Inc. (``Company'') has filed an application 
with the Securities and Exchange Commission (``Commission''), pursuant 
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and 
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified 
security (``Security'') from listing and registration on the Boston 
Stock Exchange, Inc. (``BSE'').
    The reasons alleged in the application for withdrawing the Security 
from listing and registration include the following:
    According to the Company, it is delisting the Security from the BSE 
as soon as practicable after October 6, 1995 because, commencing 
October 1995, the Security will be listed for quotation on the Nasdaq 
National Market System (``Nasdaq/NMS'') and the rules of the Nasdaq/NMS 
and the BSE do not permit a security to be listed on both the BSE and 
the Nasdaq/NMS. The Security is also currently traded on the Nasdaq 
SmallCap Market.
    Any interested person may, on or before November 9, 1995, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the 
application has been made in accordance with the rules of the BSE and 
what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 95-26381 Filed 10-24-95; 8:45 am]
BILLING CODE 8010-01-M